INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 October 2011
Total net assets |
£95.5m |
NAV per share |
171.3p |
Share price |
151.0p |
Total value of unquoted investments |
£17.5m |
Total number of portfolio companies |
68 |
Cash |
3% NAV |
Cash committed and reserved to unquoted investments |
(9)% NAV |
Portfolio companies with < 1 year of cash |
13% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen |
5.7 |
Teva |
5.1 |
Gilead Sciences |
4.5 |
Micromet |
4.5 |
Insulet |
4.1 |
Pharmaxis |
3.7 |
Celgene |
3.4 |
Shire |
3.3 |
EUSA |
3.0 |
Aptiv |
2.9 |
|
----------- |
Total |
40.2 |
Geographical Allocation |
% |
United States |
72 |
Europe |
16 |
Israel |
5 |
Australia |
4 |
Cash |
3 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
79 |
Unquoted |
18 |
Cash |
3 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
21 NOVEMBER 2011